Search results
The Oxford COVID-19 vaccine team is working at unprecedented speed in a race against the global threat to human health that is coronavirus. The University of Oxford’s Jenner Institute and Oxford Vaccine Group have been at the forefront of scientific endeavour to develop vaccines for diseases of major global importance for more than 30 years.
Feb 22, 2023 · Researchers from the University of Oxford have contributed to a global Coronavirus Vaccines Research and Development Roadmap, a comprehensive plan to galvanize efforts around the world to protect people from the effects of this large and dangerous family of viruses.
Jul 19, 2020 · The Oxford COVID-19 vaccine trials. The main focus of the Phase I, II and III studies has been to assess whether the ChAdOx1 vaccine is going to work against COVID-19, that it doesn’t cause unacceptable side effects and if it induces good immune responses.
Jul 15, 2022 · When the University of Oxford developed a vaccine that was effective against COVID-19, ensuring that it could be rolled out globally and in perpetuity for low- and middle-income countries was of paramount importance.
May 3, 2024 · A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.
To date, two billion doses of the COVID-19 vaccine developed by the University of Oxford and AstraZeneca have been released to more than 170 countries. This marks a significant milestone in the global pandemic response.
Nov 23, 2020 · The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate coronavirus vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
